Panavance Therapeutics Inc.
Panavance Therapeutics Inc. is a clinical-stage pharmaceutical company focused on developing a novel oncology platform to improve outcomes and quality of life for cancer patients. Their lead program, misetionamide (GP-2250), is a tumor cell selective small molecule with a unique dual mechanism of action targeting cancer cell energy metabolism and growth. Panavance is progressing towards registration-directed clinical studies for ovarian and pancreatic cancer treatments, with potential applications in melanoma, squamous cell, breast, and colorectal cancers. The company aims to disrupt cancer's energy and advance the effectiveness of cancer treatments globally.
Panavance Therapeutics Inc.
Panavance Therapeutics Inc. is a clinical-stage pharmaceutical company focused on developing a novel oncology platform to improve outcomes and quality of life for cancer patients. Their lead program, misetionamide (GP-2250), is a tumor cell selective small molecule with a unique dual mechanism of action targeting cancer cell energy metabolism and growth. Panavance is progressing towards registration-directed clinical studies for ovarian and pancreatic cancer treatments, with potential applications in melanoma, squamous cell, breast, and colorectal cancers. The company aims to disrupt cancer's energy and advance the effectiveness of cancer treatments globally.
panavance.com
1055 Westlakes Dr Suite 300 Berwyn, Pennsylvania 19312, US
Details
Year founded
2021
Revenue
1M-5M
Employees
1-10
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Novel Cancer Drug
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Powder Compacting Presses
- Isostatic Presses
- Piston Extruders
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
FALSE
Our production algorithm is showing that panavance therapeutics is not ramping up production.
Target industries
Employees working in Panavance Therapeutics Inc.
Locations (1)
Panavance Therapeutics Inc.
1055 Westlakes Dr Suite 300 Berwyn, Pennsylvania 19312, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Panavance Therapeutics Inc. offer?
Panavance Therapeutics Inc. offers a range of services and capabilities, including Novel Cancer Drug.
What kind of equipment does Panavance Therapeutics Inc. use?
Panavance Therapeutics Inc. uses a variety of equipment, including Powder Compacting Presses.
What are the target industries of Panavance Therapeutics Inc.?
Panavance Therapeutics Inc. serves several industries, including the medical industry.
How many locations does Panavance Therapeutics Inc. operate?
Panavance Therapeutics Inc. operates from a single location at 1055 westlakes drive suite 300, berwyn, pennsylvania 19312, united states.
Where are the headquarters of Panavance Therapeutics Inc.?
The headquarters of Panavance Therapeutics Inc. are located in 1055 westlakes drive suite 300, berwyn, pennsylvania 19312, united states.
What is the NAICS code for Panavance Therapeutics Inc.?
The NAICS code for Panavance Therapeutics Inc. is 3254.
How many employees does Panavance Therapeutics Inc. have?
Panavance Therapeutics Inc. has 9 employees.
What is the official website of Panavance Therapeutics Inc.?
The official website of Panavance Therapeutics Inc. is https://www.panavance.com/.
When was Panavance Therapeutics Inc. founded?
Panavance Therapeutics Inc. was founded in 2021.